ProCE Banner Activity

Interactive Decision Support Tool: Treatment Selection for Patients With Advanced Endometrial Cancer

Tool

Use this Interactive Decision Support Tool to compare your management of patients with advanced endometrial cancer with those of 5 renowned gynecologic oncology experts.

Released: September 13, 2022

Expiration: September 12, 2023

Share

Faculty

Maria Bell

Maria Bell, MD, MPH, MBA

Medical Director of Research
Gynecologic Oncologist
Sanford Health
Sioux Falls, South Dakota

Hye Sook Chon

Hye Sook Chon, MD

Associate Member
Clinical Trial Medical Director
Department of Gynecologic Oncology
Moffitt Cancer Center
Tampa, Florida

Linda R. Duska

Linda R. Duska, MD, MPH

Professor, Gynecologic Oncology
Vice Chair for Research
Department of Obstetrics and Gynecology
Associate Dean for Clinical Research
University of Virginia School of Medicine
Charlottesville, Virginia

Ritu Salani

Ritu Salani, MD, MBA

Professor and Division Director
OB/GYN and Gynecologic Oncology
University of California, Los Angeles
Los Angeles, California

Shannon N. Westin

Shannon N. Westin, MD, MPH

Associate Professor
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme

Faculty Disclosure

Contributing Author

Maria Bell, MD, MPH, MBA

Medical Director of Research
Gynecologic Oncologist
Sanford Health
Sioux Falls, South Dakota

Hye Sook Chon, MD

Associate Member
Clinical Trial Medical Director
Department of Gynecologic Oncology
Moffitt Cancer Center
Tampa, Florida

Hye Sook Chon, MD: consultant/advisor/speaker: Acrotech, Eisai, Merck, OncoInvent.

Linda R. Duska, MD, MPH

Professor, Gynecologic Oncology
Vice Chair for Research
Department of Obstetrics and Gynecology
Associate Dean for Clinical Research
University of Virginia School of Medicine
Charlottesville, Virginia

Linda R. Duska, MD, MPH, has no relevant financial relationships to disclose.

Ritu Salani, MD, MBA

Professor and Division Director
OB/GYN and Gynecologic Oncology
University of California, Los Angeles
Los Angeles, California

Ritu Salani, MD, MBA: consultant/advisor/speaker: GSK, Merck, Regeneron, Seagen.

Shannon N. Westin, MD, MPH

Associate Professor
Division of Surgery
Department of Gynecologic Oncology and Reproductive Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas